Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Regul Toxicol Pharmacol. 2019 Sep 20;108:104481. doi: 10.1016/j.yrtph.2019.104481

Fig. 1. Decisions for animal study waiver requests presented to HASPOC.

Fig. 1.

Left: percentage of waivers granted or denied (i.e. required studies) by HASPOC using the WOE approach. Right: breakdown of waivers granted by study type.